{"id":"https://openalex.org/W1937331920","doi":null,"title":"MECHANISMS OF DRUG ADDICTION: FOCUS ON POSITIVE REINFORCING PROPERTIES OF MORPHINE","display_name":"MECHANISMS OF DRUG ADDICTION: FOCUS ON POSITIVE REINFORCING PROPERTIES OF MORPHINE","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W1937331920","mag":"1937331920"},"language":"en","primary_location":{"id":"pmh:oai:dspace.ut.ee:10062/43200","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10062/43200","pdf_url":null,"source":{"id":"https://openalex.org/S4306401412","display_name":"DSpace repository (University of Tartu)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I56085075","host_organization_name":"University of Tartu","host_organization_lineage":["https://openalex.org/I56085075"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063475782","display_name":"Toomas Kivastik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Toomas Kivastik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5063475782"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6377000212669373,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6377000212669373,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.33889999985694885,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.9039999842643738},{"id":"https://openalex.org/keywords/conditioned-place-preference","display_name":"conditioned place preference","score":0.8349999785423279},{"id":"https://openalex.org/keywords/naloxonazine","display_name":"naloxonazine","score":0.8100000023841858},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9710000157356262},{"id":"https://openalex.org/keywords/naltrindole","display_name":"naltrindole","score":0.9980000257492065},{"id":"https://openalex.org/keywords/morphine-reward","display_name":"morphine reward","score":0.8100000023841858},{"id":"https://openalex.org/keywords/catalepsy","display_name":"catalepsy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/hyperthermia","display_name":"hyperthermia","score":0.8999999761581421},{"id":"https://openalex.org/keywords/positive-reinforcement","display_name":"positive reinforcement","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C2777953665","wikidata":"https://www.wikidata.org/wiki/Q3743642","display_name":"Naltrindole","level":5,"score":0.9719835519790649},{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.8460112810134888},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.8066911697387695},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.7506691217422485},{"id":"https://openalex.org/C35124327","wikidata":"https://www.wikidata.org/wiki/Q5159285","display_name":"Conditioned place preference","level":3,"score":0.6946911811828613},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6903470754623413},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6818691492080688},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.525432288646698},{"id":"https://openalex.org/C2776316548","wikidata":"https://www.wikidata.org/wiki/Q423380","display_name":"Oxymorphone","level":5,"score":0.4749070405960083},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.46827268600463867},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.4492906928062439},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3512306809425354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3467586040496826},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3034348487854004},{"id":"https://openalex.org/C2776029756","wikidata":"https://www.wikidata.org/wiki/Q407535","display_name":"Oxycodone","level":4,"score":0.10725286602973938},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.07169121503829956},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:dspace.ut.ee:10062/43200","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10062/43200","pdf_url":null,"source":{"id":"https://openalex.org/S4306401412","display_name":"DSpace repository (University of Tartu)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I56085075","host_organization_name":"University of Tartu","host_organization_lineage":["https://openalex.org/I56085075"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},{"id":"mag:1937331920","doi":null,"is_oa":false,"landing_page_url":"https://dspace.ut.ee/bitstream/handle/10062/43200/kivastik_mechanisms_1996.pdf;sequence=1","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W50807590","https://openalex.org/W79453320","https://openalex.org/W94483122","https://openalex.org/W166356027","https://openalex.org/W1484127898","https://openalex.org/W1893778072","https://openalex.org/W1895146805","https://openalex.org/W1964286925","https://openalex.org/W1966092598","https://openalex.org/W1967738500","https://openalex.org/W1968228025","https://openalex.org/W1968533035","https://openalex.org/W1973650559","https://openalex.org/W1973736584","https://openalex.org/W1975803363","https://openalex.org/W1978179142","https://openalex.org/W1980080792","https://openalex.org/W1988640618","https://openalex.org/W1989314580","https://openalex.org/W1991229633","https://openalex.org/W1994615753","https://openalex.org/W1996740108","https://openalex.org/W1996940755","https://openalex.org/W1999964839","https://openalex.org/W2002788998","https://openalex.org/W2005101125","https://openalex.org/W2009052530","https://openalex.org/W2011645297","https://openalex.org/W2011944526","https://openalex.org/W2013907129","https://openalex.org/W2016828293","https://openalex.org/W2017034090","https://openalex.org/W2017491485","https://openalex.org/W2017549779","https://openalex.org/W2019816442","https://openalex.org/W2024190185","https://openalex.org/W2024666284","https://openalex.org/W2025530812","https://openalex.org/W2026787509","https://openalex.org/W2032103464","https://openalex.org/W2036258040","https://openalex.org/W2041739013","https://openalex.org/W2043009865","https://openalex.org/W2045761836","https://openalex.org/W2045904887","https://openalex.org/W2050049958","https://openalex.org/W2059230444","https://openalex.org/W2061493991","https://openalex.org/W2068620648","https://openalex.org/W2070417141","https://openalex.org/W2084856596","https://openalex.org/W2084913220","https://openalex.org/W2091641405","https://openalex.org/W2092375389","https://openalex.org/W2093213504","https://openalex.org/W2093657750","https://openalex.org/W2094851904","https://openalex.org/W2094907013","https://openalex.org/W2122592499","https://openalex.org/W2163815564","https://openalex.org/W2170810822","https://openalex.org/W2267011328","https://openalex.org/W2273065775","https://openalex.org/W2347664689"],"related_works":["https://openalex.org/W2133479791","https://openalex.org/W2098179807","https://openalex.org/W2046290848","https://openalex.org/W101608061","https://openalex.org/W2066719328","https://openalex.org/W1994078305","https://openalex.org/W2011944526","https://openalex.org/W2041141923","https://openalex.org/W2060159606","https://openalex.org/W2103780725"],"abstract_inverted_index":{"PIEPPONEN,":[0],"T.":[1,3],"P.,":[2],"KIVASTIK,":[4],"J.":[5],"KATAJAMAKI,":[6],"A.":[7],"ZHARKOVSKY":[8],"AND":[9],"L.":[10],"AHTEE.":[11],"Involvement":[12],"of":[13,29,37,48,74,94],"opioid":[14,97],"pi-receptors":[15],"in":[16,21,40,177,203],"morphine-induced":[17,77,153,159,181,204],"place":[18,62,210],"prefer\u00ad":[19],"ence":[20],"rats.":[22],"PHARMACOL":[23],"BIOCHEM":[24],"BEHAV.":[25],"The":[26],"main":[27],"purpose":[28],"this":[30],"study":[31],"was":[32,123],"to":[33,57,138,186,198],"evaluate":[34],"the":[35,46,60,92],"role":[36,173],"|il-opioid":[38],"receptors":[39,176,196,216],"morphine":[41,67,118,178],"reward.":[42,205],"Therefore,":[43],"we":[44],"studied":[45],"ability":[47],"(j":[49],"1":[50,191],"selective":[51,106],"antagonist,":[52,99,109],"naloxonazine":[53,75,129],"(15":[54,79,145],"mg/kg,":[55,69,102,112],"IP),":[56,113],"an\u00ad":[58],"tagonize":[59],"conditioned":[61],"preference":[63],"(CPP)":[64],"induced":[65,116],"by":[66,117,126,143,189],"(3":[68,82,86],"SC).":[70],"In":[71],"addition,":[72],"effects":[73,93],"on":[76,114],"catalepsy":[78,154],"mg/kg),":[80],"analgesia":[81,156],"mg/kg)":[83,87],"and":[84,104,130,134,155],"hyperthermia":[85,182],"were":[88,119],"studied.":[89],"For":[90],"comparison,":[91],"a":[95,105],"non-selective":[96],"receptor":[98,108],"naltrexone":[100,131],"(2.5":[101],"SC),":[103],"8-opioid":[107],"naltrindole":[110,144],"(2":[111],"CPP":[115,122],"investigated.":[120],"Morphine-induced":[121],"clearly":[124],"antagonized":[125,152],"pretreatment":[127],"with":[128],"(12":[132],"h":[133],"20":[135],"min":[136,146],"prior":[137],"morphine,":[139],"respectively)":[140],"but":[141,157],"not":[142,158,163,184],"before":[147],"mor\u00ad":[148],"phine).":[149],"Naloxonazine":[150],"also":[151],"hyperthermia.":[160],"Naltrindole":[161],"did":[162],"modify":[164],"morphine-in-":[165],"duced":[166],"catalepsy.":[167],"These":[168],"results":[169],"suggest":[170],"an":[171],"active":[172],"for":[174],"pi-opioid":[175],"reward,":[179],"whereas":[180],"does":[183],"appear":[185],"be":[187,199],"mediated":[188],"jn":[190],"-opioid":[192],"receptors.":[193],"Furthermore,":[194],"5-opioid":[195],"seem":[197],"with\u00ad":[200],"out":[201],"significance":[202],"Naltrexone,":[206],"Naloxonazine,":[207],"Naltrindole,":[208],"Conditioned":[209],"preference,":[211],"Catalepsy,":[212],"Analgesia,":[213],"Hyperthermia,":[214],"Opioid":[215]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-08-18T07:49:30.821534","created_date":"2016-06-24T00:00:00"}